Albumin-Bilirubin Score: Predicting Short-Term Outcomes Including Bile Leak and Post-hepatectomy Liver Failure Following Hepatic Resection JOURNAL OF GASTROINTESTINAL SURGERY Andreatos, N., Amini, N., Gani, F., Margonis, G. A., Sasaki, K., Thompson, V. M., Bentrem, D. J., Hall, B. L., Pitt, H. A., Wilson, A., Pawlik, T. M. 2017; 21 (2): 238-248


Post-operative bile leak (BL) and post hepatectomy liver failure (PHLF) are the major potential sources of morbidity among patients undergoing liver resection. We sought to define the incidence of BL and PHLF among a large cohort of patients, as well as examine the prognostic impact of model for end-stage liver disease (MELD) and albumin-bilirubin (ALBI) scores to predict these short-term outcomes.Patients who underwent a hepatectomy between January 1, 2014 and December 31, 2014 were identified using the National Surgical Quality Improvement Program (NSQIP) liver-targeted database. Risk factors for BL and PHLF were identified using multivariable logistic regression.Among the 3064 patients identified, median age was 60 years (IQR 50-68). Most patients underwent surgery (78.9 %) for malignant lesions. Post-operatively, 250 (8.5 %) patients experienced a BL while PHLF occurred in 149 cases (4.9 %). Both MELD (MELD <10 4.9 %; MELD =10, 10 %; P?=?0.001) and ALBI (grade 1, 4.0 %; grade 2, 7.2 %; grade 3, 10.0 %; P?=?0.001) were associated with PHLF occurrence, while only ALBI predicted PHLF severity (P?=?0.008). Moreover, ALBI was associated with BL (grade 1, 7.1 %; grade 2, 11.5 %; grade 3, 14.0 %; P?

View details for DOI 10.1007/s11605-016-3246-4

View details for Web of Science ID 000393825300005

View details for PubMedID 27619809